Geoff Meacham
Stock Analyst at Citigroup
(3.58)
# 795
Out of 4,840 analysts
243
Total ratings
52.67%
Success rate
3.41%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Upgrades: Buy | $600 → $700 | $588.34 | +18.98% | 21 | May 14, 2025 | |
| ABBV AbbVie | Downgrades: Neutral | $210 → $205 | $183.26 | +11.86% | 17 | May 14, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Neutral | $47 → $44 | $29.50 | +49.15% | 5 | May 12, 2025 | |
| PTCT PTC Therapeutics | Upgrades: Neutral | $50 → $40 | $45.93 | -12.91% | 8 | May 7, 2025 | |
| BNTX BioNTech SE | Maintains: Buy | $145 → $140 | $98.68 | +41.87% | 2 | May 6, 2025 | |
| NMRA Neumora Therapeutics | Downgrades: Underperform | $7 → $1 | $0.68 | +47.12% | 3 | Apr 2, 2025 | |
| MRNA Moderna | Initiates: Neutral | $40 | $26.26 | +52.32% | 10 | Mar 13, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Initiates: Buy | $40 | $26.89 | +48.75% | 3 | Mar 13, 2025 | |
| RNA Avidity Biosciences | Initiates: Buy | $70 | $30.58 | +128.91% | 4 | Mar 13, 2025 | |
| APGE Apogee Therapeutics | Initiates: Buy | $95 | $39.48 | +140.63% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $9.49 | +163.44% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $57.55 | +78.97% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $145 | $125.81 | +15.25% | 14 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $310 → $295 | $271.66 | +8.59% | 11 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $85 | $36.86 | +130.60% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $1.39 | +187.77% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $45 | $33.34 | +34.97% | 5 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $107.37 | +16.42% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $436.00 | +31.88% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $713.71 | +54.12% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6 → $1 | $0.42 | +139.18% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $9.35 | +231.73% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $0.33 | +2,903.91% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $77.58 | +86.90% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $152.94 | +11.15% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $38 | $32.45 | +17.10% | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $25.22 | +90.33% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $46.85 | +28.07% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 | $1.26 | +537.45% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $4.50 | +211.11% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $4.09 | +95.60% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.62 | +2,656.16% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $14 | $1.02 | +1,272.55% | 3 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $23.32 | +92.97% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $5.31 | +841.62% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $1.97 | +1,118.27% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $3.16 | +26.58% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.22 | +2,195.08% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.56 | +5,984.47% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $4.32 | +1,196.30% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $0.79 | +4,328.70% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $2.99 | +17,458.53% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $0.91 | +4,535.76% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $5.11 | +291.39% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.47 | +4,125.65% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $3.24 | +177.78% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $9.71 | +517.92% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $4.23 | +65.48% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $11.54 | +99.31% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $64.25 | +27.63% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $307.65 | -69.12% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $8.53 | +838.42% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $120.18 | +12.33% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $6.58 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $0.57 | +3,431.70% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $15.64 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $289.96 | -45.51% | 5 | Nov 8, 2017 |
Regeneron Pharmaceuticals
May 14, 2025
Upgrades: Buy
Price Target: $600 → $700
Current: $588.34
Upside: +18.98%
AbbVie
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $183.26
Upside: +11.86%
Kymera Therapeutics
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $29.50
Upside: +49.15%
PTC Therapeutics
May 7, 2025
Upgrades: Neutral
Price Target: $50 → $40
Current: $45.93
Upside: -12.91%
BioNTech SE
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $98.68
Upside: +41.87%
Neumora Therapeutics
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $0.68
Upside: +47.12%
Moderna
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $26.26
Upside: +52.32%
Kiniksa Pharmaceuticals International,
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $26.89
Upside: +48.75%
Avidity Biosciences
Mar 13, 2025
Initiates: Buy
Price Target: $70
Current: $30.58
Upside: +128.91%
Apogee Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $39.48
Upside: +140.63%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $9.49
Upside: +163.44%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $57.55
Upside: +78.97%
Feb 13, 2025
Maintains: Neutral
Price Target: $160 → $145
Current: $125.81
Upside: +15.25%
Jan 28, 2025
Maintains: Neutral
Price Target: $310 → $295
Current: $271.66
Upside: +8.59%
Jan 7, 2025
Maintains: Buy
Price Target: $98 → $85
Current: $36.86
Upside: +130.60%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $1.39
Upside: +187.77%
Nov 25, 2024
Maintains: Buy
Price Target: $42 → $45
Current: $33.34
Upside: +34.97%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $107.37
Upside: +16.42%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $436.00
Upside: +31.88%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $713.71
Upside: +54.12%
Oct 30, 2024
Downgrades: Underperform
Price Target: $6 → $1
Current: $0.42
Upside: +139.18%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $9.35
Upside: +231.73%
Aug 19, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $0.33
Upside: +2,903.91%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $77.58
Upside: +86.90%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $152.94
Upside: +11.15%
Apr 12, 2024
Maintains: Buy
Price Target: $40 → $38
Current: $32.45
Upside: +17.10%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $25.22
Upside: +90.33%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $46.85
Upside: +28.07%
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $1.26
Upside: +537.45%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $4.50
Upside: +211.11%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $4.09
Upside: +95.60%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.62
Upside: +2,656.16%
Jul 20, 2023
Reinstates: Buy
Price Target: $14
Current: $1.02
Upside: +1,272.55%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $23.32
Upside: +92.97%
Jan 5, 2023
Initiates: Buy
Price Target: $50
Current: $5.31
Upside: +841.62%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $1.97
Upside: +1,118.27%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $3.16
Upside: +26.58%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.22
Upside: +2,195.08%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.56
Upside: +5,984.47%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $4.32
Upside: +1,196.30%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $0.79
Upside: +4,328.70%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $2.99
Upside: +17,458.53%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $0.91
Upside: +4,535.76%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $5.11
Upside: +291.39%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.47
Upside: +4,125.65%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $3.24
Upside: +177.78%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $9.71
Upside: +517.92%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $4.23
Upside: +65.48%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $11.54
Upside: +99.31%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $64.25
Upside: +27.63%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $307.65
Upside: -69.12%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $8.53
Upside: +838.42%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $120.18
Upside: +12.33%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $6.58
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $0.57
Upside: +3,431.70%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $15.64
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $289.96
Upside: -45.51%